{"id":"iv-antibacterial-agents","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypersensitivity reactions"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Ototoxicity"},{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Phlebitis at injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a broad category encompassing multiple classes of intravenous antibiotics (e.g., beta-lactams, aminoglycosides, fluoroquinolones, glycopeptides) that work through distinct mechanisms. Common mechanisms include inhibition of bacterial cell wall synthesis, disruption of protein translation, or interference with nucleic acid replication. The specific mechanism depends on the individual antibiotic within this class.","oneSentence":"IV antibacterial agents kill or inhibit the growth of bacteria through various mechanisms including cell wall disruption, protein synthesis inhibition, or DNA damage.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:50:31.676Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections requiring intravenous administration (broad spectrum)"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT05698823","phase":"NA","title":"Regular Home-use of Dual-light Photodynamic Therapy in the Management of Chronic Stage III-IV Periodontitis","status":"COMPLETED","sponsor":"Koite Health Oy","startDate":"2023-06-06","conditions":"Periodontitis Chronic Generalized Moderate, Periodontitis Chronic Generalized Severe","enrollment":56},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07041736","phase":"NA","title":"Evaluating Postoperative Pain and Antibacterial Effect of Ultrasonic and 980 nm Diode Laser Combination","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2025-08-03","conditions":"Post Operative Pain","enrollment":120},{"nctId":"NCT06080698","phase":"NA","title":"Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-02-22","conditions":"Gram-negative Bacteremia","enrollment":1030},{"nctId":"NCT06889701","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants","status":"RECRUITING","sponsor":"TenNor Therapeutics Inc.","startDate":"2025-04-03","conditions":"Periprosthetic Joint Infection (PJI)","enrollment":33},{"nctId":"NCT04678869","phase":"NA","title":"CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College, London","startDate":"2022-06-29","conditions":"Acute Lymphoblastic Leukaemia - Category","enrollment":313},{"nctId":"NCT04368559","phase":"PHASE3","title":"Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mundipharma Research Limited","startDate":"2020-05-11","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":602},{"nctId":"NCT05699174","phase":"PHASE3","title":"PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation","status":"RECRUITING","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2023-05-30","conditions":"Infections, Infected Wound, Nonunion of Fracture","enrollment":250},{"nctId":"NCT06229288","phase":"PHASE3","title":"Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-04-25","conditions":"Community-acquired Pneumonia","enrollment":326},{"nctId":"NCT05753215","phase":"PHASE2","title":"Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-05-09","conditions":"Bone Infection, Joint Infection, Bone and Joint Infection","enrollment":180},{"nctId":"NCT05544565","phase":"PHASE4","title":"3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-22","conditions":"Pyelonephritis Acute","enrollment":480},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":"E Coli Infection, ESBL Producing E.Coli","enrollment":84},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":"Aspiration, Aspiration Pneumonia","enrollment":5},{"nctId":"NCT05640336","phase":"NA","title":"Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2023-03-03","conditions":"Periprosthetic Joint Infection","enrollment":490},{"nctId":"NCT04722978","phase":"PHASE3","title":"Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer","status":"RECRUITING","sponsor":"Sun Yat-Sen University Cancer Center","startDate":"2021-04-20","conditions":"Triple Negative Breast Cancer","enrollment":228},{"nctId":"NCT06672978","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis","status":"RECRUITING","sponsor":"Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)","startDate":"2025-06-03","conditions":"Acute Pyelonephritis, Complicated Urinary Tract Infection","enrollment":66},{"nctId":"NCT03012360","phase":"PHASE4","title":"Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2018-02-08","conditions":"Mechanical Ventilation Complication, Critical Illness","enrollment":103},{"nctId":"NCT04876131","phase":"PHASE4","title":"Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children","status":"RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-05-30","conditions":"Complicated Urinary Tract Infection, Infection, Pediatric Infectious Disease","enrollment":452},{"nctId":"NCT06621251","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection","status":"RECRUITING","sponsor":"Trellis Bioscience LLC","startDate":"2025-04-08","conditions":"Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee","enrollment":60},{"nctId":"NCT07203638","phase":"NA","title":"Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Esraa Salah Mohamed Abdallah Eladl","startDate":"2024-11-01","conditions":"Ventilator-Associated Pneumonia (VAP)","enrollment":100},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT07097727","phase":"PHASE1","title":"Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-10-30","conditions":"Ventilator Associated Pneumonia ( VAP), Mechanical Ventilation","enrollment":70},{"nctId":"NCT07089186","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-04-12","conditions":"Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI)","enrollment":80},{"nctId":"NCT02687906","phase":"PHASE1","title":"Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)","startDate":"2016-07","conditions":"Bacterial Infections","enrollment":39},{"nctId":"NCT05462496","phase":"PHASE2","title":"Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-03-16","conditions":"Pancreatic Cancer","enrollment":25},{"nctId":"NCT06607887","phase":"PHASE4","title":"The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy","status":"RECRUITING","sponsor":"Minia University Hospital","startDate":"2024-08-30","conditions":"Infection Wound, Antibiotic Resistant Infection","enrollment":300},{"nctId":"NCT06597825","phase":"NA","title":"Antibacterial Effect of NaOCl With Etidronic Acid in Apical Periodontitis Treatment","status":"COMPLETED","sponsor":"Mustafa Kemal University","startDate":"2020-08-17","conditions":"Healthy","enrollment":40},{"nctId":"NCT06527560","phase":"PHASE4","title":"Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-09-09","conditions":"Pyelonephritis in Pregnancy","enrollment":100},{"nctId":"NCT02907359","phase":"PHASE3","title":"Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs","status":"COMPLETED","sponsor":"Astex Pharmaceuticals, Inc.","startDate":"2017-01-13","conditions":"Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic","enrollment":417},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT03817125","phase":"PHASE1","title":"Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention","status":"COMPLETED","sponsor":"Parker Institute for Cancer Immunotherapy","startDate":"2019-01-28","conditions":"Metastatic Melanoma","enrollment":14},{"nctId":"NCT06422533","phase":"NA","title":"Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients","status":"RECRUITING","sponsor":"Instituto Nacional de Cancerologia de Mexico","startDate":"2023-11-07","conditions":"Hematologic Neoplasms, Neutropenia","enrollment":226},{"nctId":"NCT05724628","phase":"PHASE1","title":"Non-operative vs. Operative Management of Acute Appendicitis in Vulnerable Patient Populations","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-10","conditions":"Acute Appendicitis","enrollment":""},{"nctId":"NCT04989127","phase":"","title":"Comparison The Postoperative Effects of Local and Systemic Antibiotics Applied With Platelets Rich Fibrin","status":"COMPLETED","sponsor":"Ceren Melahat Donmezer","startDate":"2019-03-17","conditions":"Impacted Wisdom Tooth","enrollment":75},{"nctId":"NCT06084754","phase":"NA","title":"Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-11-27","conditions":"Osteomyelitis","enrollment":20},{"nctId":"NCT02409290","phase":"PHASE3","title":"The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB","status":"COMPLETED","sponsor":"IUATLD, Inc","startDate":"2016-03","conditions":"MDR-TB","enrollment":588},{"nctId":"NCT03182907","phase":"PHASE3","title":"Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-03-27","conditions":"Clostridium Difficile Infection","enrollment":148},{"nctId":"NCT05678296","phase":"","title":"Investigation of Effectiveness of Local Antibiotic With Platelet Rich Fibrin on Third Molar Surgery Outcomes In Vivo","status":"COMPLETED","sponsor":"Ceren Melahat Donmezer","startDate":"2020-04-20","conditions":"Impacted Wisdom Tooth, Pain, Staphylococcus Aureus","enrollment":60},{"nctId":"NCT05393505","phase":"PHASE4","title":"Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-10-24","conditions":"Neutropenic Fever","enrollment":344},{"nctId":"NCT01539811","phase":"NA","title":"Diabetic Foot Infection Antibiotic Study","status":"TERMINATED","sponsor":"Prisma Health-Upstate","startDate":"2012-02","conditions":"Diabetic Foot Infections","enrollment":2},{"nctId":"NCT04335305","phase":"PHASE2","title":"Checkpoint Blockade in COVID-19 Pandemic","status":"TERMINATED","sponsor":"MedSIR","startDate":"2020-04-09","conditions":"COVID-19, Pneumonia, Viral","enrollment":12},{"nctId":"NCT05328817","phase":"NA","title":"Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes","status":"UNKNOWN","sponsor":"Eastern Virginia Medical School","startDate":"2022-05-01","conditions":"Preterm Premature Rupture of Membrane","enrollment":240},{"nctId":"NCT03163446","phase":"PHASE2","title":"Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia","status":"COMPLETED","sponsor":"ContraFect","startDate":"2017-05-23","conditions":"Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis","enrollment":121},{"nctId":"NCT03768869","phase":"PHASE3","title":"Fever and Neutropenia in Pediatric Oncology Patients","status":"WITHDRAWN","sponsor":"University of Colorado, Denver","startDate":"2006-02","conditions":"Fever, Neutropenia","enrollment":""},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT01479283","phase":"PHASE3","title":"Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)","status":"COMPLETED","sponsor":"McMaster University","startDate":"2013-01","conditions":"Infection, Bone Neoplasms","enrollment":602},{"nctId":"NCT00462020","phase":"NA","title":"Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2007-03","conditions":"Perforated Appendicitis","enrollment":102},{"nctId":"NCT04412291","phase":"PHASE2","title":"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study","status":"UNKNOWN","sponsor":"Karolinska University Hospital","startDate":"2020-06-11","conditions":"Covid-19","enrollment":120},{"nctId":"NCT03583749","phase":"","title":"Pharmacokinetics and Safety of Antimicrobial Agents Administered by Subcutaneous Route in Patients AGEd Over 65 Years","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2019-08-07","conditions":"Antimicrobials, Subcutaneous Injection, Antibiotic","enrollment":150},{"nctId":"NCT04731090","phase":"NA","title":"Standard Antibiotic Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy","status":"COMPLETED","sponsor":"Egyptian Biomedical Research Network","startDate":"2018-08-01","conditions":"Urinary Tract Infections","enrollment":100},{"nctId":"NCT04365270","phase":"PHASE3","title":"Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-01-15","conditions":"Reversible Pulpitis, Pulpitis, Caries,Dental","enrollment":65},{"nctId":"NCT04615702","phase":"","title":"Evidence Based Management of Acute Biliary Pancreatitis","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2017-05-15","conditions":"Acute Pancreatitis","enrollment":30},{"nctId":"NCT03563586","phase":"NA","title":"Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer Surgery","status":"UNKNOWN","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-04-01","conditions":"Antibiotic, Bowel Cancer, Colorectal Cancer","enrollment":210},{"nctId":"NCT02027428","phase":"PHASE3","title":"Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"Celgene","startDate":"2014-02-11","conditions":"Squamous Cell Carcinoma, Non-Small-Cell Lung","enrollment":427},{"nctId":"NCT03051698","phase":"PHASE4","title":"C1-inhibitor in Allergic ASThma Patients","status":"TERMINATED","sponsor":"T. van der Poll","startDate":"2016-11-16","conditions":"Asthma","enrollment":37},{"nctId":"NCT02070757","phase":"PHASE3","title":"Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2014-09-02","conditions":"Healthcare-Associated Pneumonia, Ventilator-Associated Pneumonia, Lung Diseases","enrollment":726},{"nctId":"NCT02961764","phase":"PHASE4","title":"Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)","status":"COMPLETED","sponsor":"Allergan","startDate":"2016-11-29","conditions":"Acute Bacterial Skin and Skin Structure Infections","enrollment":313},{"nctId":"NCT02679573","phase":"PHASE3","title":"Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2016-12-14","conditions":"Community Acquired Bacterial Pneumonia","enrollment":860},{"nctId":"NCT03233438","phase":"PHASE4","title":"Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)","status":"COMPLETED","sponsor":"Allergan","startDate":"2017-07-24","conditions":"Bacterial Infections, Acute Bacterial Skin and Skin Structure Infection","enrollment":91},{"nctId":"NCT04146883","phase":"NA","title":"Post-procedure Antibiotic Prophylaxis for Cardiac Electrical Device Implantation: ABxFREE Study","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2019-08-20","conditions":"Post Procedural Infection, Pacemaker Electrode Infection, Antibiotics","enrollment":800},{"nctId":"NCT00589329","phase":"NA","title":"Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam","status":"TERMINATED","sponsor":"MetroHealth Medical Center","startDate":"2007-12","conditions":"Length of Pregnancy Prolongation in Hours","enrollment":20},{"nctId":"NCT03477422","phase":"PHASE3","title":"CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2014-01-11","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":230},{"nctId":"NCT01743560","phase":"PHASE4","title":"An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-01-31","conditions":"Oestrogen Receptor Positive Advanced Breast Cancer","enrollment":52},{"nctId":"NCT00891527","phase":"PHASE1, PHASE2","title":"Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2008-10","conditions":"Pulmonary Veno Occlusive Disease","enrollment":50},{"nctId":"NCT02855359","phase":"PHASE2","title":"Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma","status":"TERMINATED","sponsor":"Seagen Inc.","startDate":"2016-08","conditions":"Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL","enrollment":24},{"nctId":"NCT02168946","phase":"PHASE3","title":"Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults","status":"COMPLETED","sponsor":"Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)","startDate":"2014-07","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis, Hospital Acquired Bacterial Pneumonia","enrollment":77},{"nctId":"NCT01970371","phase":"PHASE3","title":"A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)","status":"COMPLETED","sponsor":"Achaogen, Inc.","startDate":"2014-09-16","conditions":"Bloodstream Infections (BSI) Due to CRE, Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE, Ventilator-Associated Bacterial Pneumonia (VABP) Due to CRE","enrollment":69},{"nctId":"NCT01967758","phase":"PHASE1","title":"Phase I Study of Safety and Immunogenicity of ADU-623","status":"COMPLETED","sponsor":"Providence Health & Services","startDate":"2014-01-08","conditions":"Astrocytic Tumors, Glioblastoma Multiforme, Anaplastic Astrocytoma","enrollment":11},{"nctId":"NCT02168816","phase":"PHASE2","title":"Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis","status":"TERMINATED","sponsor":"Loyola University","startDate":"2014-03-19","conditions":"Osteomyelitis","enrollment":30},{"nctId":"NCT02166476","phase":"PHASE3","title":"Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2014-11-20","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":550},{"nctId":"NCT03131141","phase":"PHASE1","title":"A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781","status":"COMPLETED","sponsor":"Nabriva Therapeutics AG","startDate":"2017-01-08","conditions":"Healthy","enrollment":10},{"nctId":"NCT03473210","phase":"NA","title":"The Value of Amniopatch in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-10-01","conditions":"Preterm Premature Rupture of Membrane","enrollment":100},{"nctId":"NCT02188758","phase":"","title":"Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2014-07","conditions":"Cystic Fibrosis","enrollment":20},{"nctId":"NCT03449940","phase":"NA","title":"Penile Fracture: A Comparison of Erectile Function After Immediate Repair Versus Delayed Repair","status":"COMPLETED","sponsor":"Ministry of Health, Jamaica","startDate":"2015-01","conditions":"Erectile Dysfunction","enrollment":46},{"nctId":"NCT00932152","phase":"PHASE2","title":"Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2010-09","conditions":"Non-small Cell Lung Cancer, Postmenopausal Women","enrollment":3},{"nctId":"NCT01811732","phase":"PHASE3","title":"Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections","status":"COMPLETED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2013-04","conditions":"Skin and Subcutaneous Tissue Bacterial Infections","enrollment":660},{"nctId":"NCT01499290","phase":"PHASE3","title":"Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-03","conditions":"Complicated Intra-Abdominal Infection","enrollment":493},{"nctId":"NCT01042704","phase":"PHASE1","title":"Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma","status":"COMPLETED","sponsor":"Robert Redner, MD","startDate":"2008-02","conditions":"Myeloma","enrollment":29},{"nctId":"NCT00324324","phase":"PHASE3","title":"Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2006-05","conditions":"Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor","enrollment":240},{"nctId":"NCT00424190","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-02","conditions":"Bacterial Infections","enrollment":698},{"nctId":"NCT00423657","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-03","conditions":"Bacterial Infections","enrollment":680},{"nctId":"NCT02736682","phase":"PHASE4","title":"Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section.","status":"COMPLETED","sponsor":"Makerere University","startDate":"2015-09","conditions":"Post Operative Infections","enrollment":174},{"nctId":"NCT02274207","phase":"PHASE4","title":"Comparative Study of Antibacterial Effect on Silver Dressing of Negative Pressure Wound","status":"UNKNOWN","sponsor":"Severance Hospital","startDate":"2014-12","conditions":"Diabetes Mellitus","enrollment":74},{"nctId":"NCT00418470","phase":"PHASE4","title":"Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People","status":"TERMINATED","sponsor":"University of Florence","startDate":"2007-03","conditions":"Cystic Fibrosis, Phlebitis","enrollment":60},{"nctId":"NCT01290003","phase":"NA","title":"Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor","status":"COMPLETED","sponsor":"Lady Hardinge Medical College","startDate":"2010-06","conditions":"Neonatal Sepsis","enrollment":250},{"nctId":"NCT02443064","phase":"PHASE4","title":"Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin","status":"UNKNOWN","sponsor":"Zhejiang University","startDate":"2014-01","conditions":"Blood Stream Infections, Endocarditis, MRSA","enrollment":100},{"nctId":"NCT01519661","phase":"PHASE4","title":"Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-01","conditions":"Pulmonary Infections, Pseudomonas Aeruginosa in Cystic Fibrosis","enrollment":157},{"nctId":"NCT01114516","phase":"NA","title":"Multifactorial Approach to Emergent Cerclage","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2010-03","conditions":"Cervical Insufficiency","enrollment":53},{"nctId":"NCT02198001","phase":"NA","title":"Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction","status":"UNKNOWN","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2014-01","conditions":"Bisphosphonate-Associated Osteonecrosis of the Jaw","enrollment":100},{"nctId":"NCT01049633","phase":"","title":"B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure","status":"NO_LONGER_AVAILABLE","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Type 1 Diabetes Mellitus","enrollment":""},{"nctId":"NCT00365274","phase":"PHASE2","title":"SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2006-08","conditions":"Anaplastic Large Cell Lymphoma","enrollment":6},{"nctId":"NCT00982540","phase":"NA","title":"Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients","status":"TERMINATED","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2010-02","conditions":"Invasive Fungal Infections, Invasive Aspergillosis, Invasive Fusariosis","enrollment":28},{"nctId":"NCT01772836","phase":"PHASE1","title":"Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination","status":"COMPLETED","sponsor":"Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)","startDate":"2013-03","conditions":"Healthy Volunteers, Bacterial Infections","enrollment":30},{"nctId":"NCT00724529","phase":"","title":"Post Marketing Surveillance of Remicade","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2007-06","conditions":"Crohn's Disease, Ankylosing Spondylitis","enrollment":938},{"nctId":"NCT01220661","phase":"PHASE2","title":"Safety and Efficacy of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2010-10","conditions":"Colorectal Surgery","enrollment":312},{"nctId":"NCT00136656","phase":"PHASE4","title":"Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2005-07","conditions":"Pyelonephritis","enrollment":700}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":239,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"IV Antibacterial Agents","genericName":"IV Antibacterial Agents","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IV antibacterial agents kill or inhibit the growth of bacteria through various mechanisms including cell wall disruption, protein synthesis inhibition, or DNA damage. Used for Bacterial infections requiring intravenous administration (broad spectrum).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}